These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32353358)

  • 41. Successful placement of the Essure device after a failed procedure using the Adiana system for hysteroscopic sterilisation.
    Schuurman T; Veersema S
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22689274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of Hysterosalpingo-Foam Sonography for Assessment of the Efficacy of Essure Hysteroscopic Sterilization.
    Rosič M; Žegura B; Vadnjal Đonlagić S
    J Ultrasound Med; 2018 Aug; 37(8):1929-1935. PubMed ID: 29344973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Symptom related to Essure® and evolution after removal: Outcomes of retrospective cohort.
    Leleu A; Cathelain A; Rubod C; Vandendriessche D; Cosson M; Giraudet G
    J Gynecol Obstet Hum Reprod; 2021 Mar; 50(3):101836. PubMed ID: 32590111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Placement of the Essure permanent birth control device with fluoroscopic guidance: a novel method for tubal sterilization.
    McSwain H; Shaw C; Hall LD
    J Vasc Interv Radiol; 2005 Jul; 16(7):1007-12. PubMed ID: 16002509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Confirmation of Essure microinsert tubal coil placement with conventional and volume-contrast imaging three-dimensional ultrasound.
    Thiel JA; Suchet IB; Lortie K
    Fertil Steril; 2005 Aug; 84(2):504-8. PubMed ID: 16084897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histopathologic Features of Postablation Tubal Sterilization Syndrome.
    Butnor KJ; Bartlett JR
    Am J Surg Pathol; 2018 Jun; 42(6):786-790. PubMed ID: 29505424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Office ultrasound should be the first-line investigation for confirmation of correct ESSURE placement.
    Weston G; Bowditch J
    Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):312-5. PubMed ID: 16029299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical removal of essure® micro inserts by vaginal hysterectomy or laparoscopic salpingectomy with cornuectomy: Case series and follow up survey about device-attributed symptoms resolution.
    Jegaden M; Pourcelot AG; Fernandez H; Capmas P
    J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101781. PubMed ID: 32492524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Confirmation of the systematic presence of tin particles in fallopian tubes or uterine horns of Essure implant explanted patients: A study of 18 cases with the same pathological process.
    Catinon M; Roux E; Auroux A; Trunfio-Sfarghiu AM; Lauro-Colleaux C; Watkin E; Sournies G; Vincent M
    J Trace Elem Med Biol; 2022 Jan; 69():126891. PubMed ID: 34749033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Technique for Essure Reversal.
    Clark NV; Einarsson JI
    JSLS; 2019; 23(1):. PubMed ID: 30846897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Referrals for complications following hysteroscopic sterilisation: characteristics associated with symptomatic patients after the Essure procedure.
    Sills ES; Dalton MM
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):227-33. PubMed ID: 27020693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Essure removal: comparison of two minimally invasive approaches.
    Gracia M; Herráez A; Coronado P
    Fertil Steril; 2020 Jul; 114(1):187-188. PubMed ID: 32622410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and patients' satisfaction after hysteroscopic sterilisation.
    Cabezas-Palacios MN; Jiménez-Caraballo A; Tato-Varela S; Sánchez-Sánchez A; Romero-Díaz C; Carrasco-Gallego A; Zapardiel-Gutiérrez I
    J Obstet Gynaecol; 2018 Apr; 38(3):377-381. PubMed ID: 29046105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of perforated essure with migration into small and large bowel mesentery.
    Braginsky L; George ST; Locher SR
    J Minim Invasive Gynecol; 2015; 22(3):504-8. PubMed ID: 25460518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tubal perforation by ESSURE microinsert.
    Thoma V; Chua I; Garbin O; Hummel M; Wattiez A
    J Minim Invasive Gynecol; 2006; 13(2):161-3. PubMed ID: 16527721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case report of failed tubal occlusion using Essure pbc (permanent birth control) hysteroscopic sterilisation procedure.
    Karthigasu KA; Garry R; Hart R
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):365-7. PubMed ID: 16866803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laparoscopic salpingectomy and removal of Essure hysteroscopic sterilisation device: a case series.
    Johal T; Kuruba N; Sule M; Mukhopadhyay S; Raje G
    Eur J Contracept Reprod Health Care; 2018 Jun; 23(3):227-230. PubMed ID: 29842838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hysteroscopic tubal sterilization: a systematic review of the Essure system.
    Hurskainen R; Hovi SL; Gissler M; Grahn R; Kukkonen-Harjula K; Nord-Saari M; Mäkelä M
    Fertil Steril; 2010 Jun; 94(1):16-9. PubMed ID: 19409549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical Management After Hysteroscopic Sterilization: Minimally Invasive Approach Incorporating Intraoperative Fluoroscopy for Symptomatic Patients with >2 Essure® Devices.
    Sills ES; Rickers NS; Li X
    Surg Technol Int; 2018 Jun; 32():156-161. PubMed ID: 29791712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Techniques for removal of the Essure hysteroscopic tubal occlusion device.
    Lannon BM; Lee SY
    Fertil Steril; 2007 Aug; 88(2):497.e13-4. PubMed ID: 17397840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.